HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olli Yli-Harja Selected Research

Purinergic P2Y1 Receptors

1/2022P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer.
10/2021Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis.
12/2019Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olli Yli-Harja Research Topics

Disease

28Neoplasms (Cancer)
10/2022 - 06/2004
13Glioblastoma (Glioblastoma Multiforme)
12/2021 - 02/2013
8Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2015
5Breast Neoplasms (Breast Cancer)
10/2022 - 01/2020
5Glioma (Gliomas)
01/2019 - 02/2013
3Osteosarcoma (Osteogenic Sarcoma)
02/2018 - 09/2016
2Alzheimer Disease (Alzheimer's Disease)
12/2019 - 01/2018
1Disease Progression
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2021
1Neuralgia (Stump Neuralgia)
12/2019
1Hepatocellular Carcinoma (Hepatoma)
07/2018
1Colorectal Neoplasms (Colorectal Cancer)
07/2018
1Parkinson Disease (Parkinson's Disease)
01/2018
1Multiple Sclerosis
01/2018
1Astrocytoma (Pilocytic Astrocytoma)
01/2017
1Ependymoma
01/2017
1Starvation
07/2016
1Chromosome Aberrations (Chromosome Abnormalities)
02/2013
1Carcinogenesis
02/2013
1Sarcoma (Soft Tissue Sarcoma)
01/2011
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2011
1Leiomyosarcoma
01/2011
1Infections
07/2010
1Lymphoma (Lymphomas)
10/2006
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2006
1Neuroblastoma
03/2006
1Neoplasm Metastasis (Metastasis)
06/2004
1Lymphatic Metastasis
06/2004

Drug/Important Bio-Agent (IBA)

10Pharmaceutical PreparationsIBA
01/2021 - 01/2013
6Phenol (Carbolic Acid)FDA Link
04/2020 - 01/2017
5G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 - 01/2018
5Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2010
5Proteins (Proteins, Gene)FDA Link
09/2021 - 07/2007
4indolineIBA
10/2022 - 09/2016
4LigandsIBA
12/2021 - 12/2019
4Biological ProductsIBA
01/2021 - 06/2004
3Purinergic P2Y1 ReceptorsIBA
01/2022 - 12/2019
3RNA (Ribonucleic Acid)IBA
01/2019 - 02/2013
3Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 07/2018
3Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
09/2017 - 02/2013
3Transcription Factors (Transcription Factor)IBA
10/2015 - 01/2011
2indoleIBA
12/2021 - 08/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 02/2013
2Tyrosine Kinase InhibitorsIBA
12/2020 - 12/2019
2N-(2-hydroxy-5-nitrophenyl (4'-methylphenyl) methyl) indolineIBA
08/2020 - 02/2018
2CaspasesIBA
08/2020 - 02/2018
2Caspase 3 (Caspase-3)IBA
01/2020 - 10/2018
2Purinergic Receptors (Receptors, Purine)IBA
12/2019 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018 - 02/2018
2Protein Isoforms (Isoforms)IBA
10/2015 - 03/2015
2AndrogensIBA
10/2015 - 03/2015
1Epidermal Growth Factor (EGF)IBA
10/2022
1Abiraterone AcetateIBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1GuanineIBA
09/2021
1LeukotrienesIBA
09/2021
1Uracil NucleotidesIBA
09/2021
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
11/2020
1Quinic Acid (Quinate)IBA
11/2020
1polyolIBA
11/2020
1Therapeutic UsesIBA
10/2020
1ErbB Receptors (EGF Receptor)IBA
08/2020
1EnzymesIBA
01/2020
1Caspase 9IBA
01/2020
1Valine (L-Valine)FDA Link
07/2019
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
03/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2019
1Protein Kinases (Protein Kinase)IBA
03/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1CDC2 Protein Kinase (Protein p34cdc2)IBA
01/2019
1Cyclin A2IBA
01/2019
1CyclinsIBA
01/2019
1Growth InhibitorsIBA
03/2018
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2017
1morpholineIBA
09/2016
1magnesium phosphateIBA
07/2016
1Thiamine (Aneurin)FDA Link
07/2016
1Glucose (Dextrose)FDA LinkGeneric
07/2016
1Long Noncoding RNAIBA
10/2015
1Kazal Pancreatic Trypsin InhibitorIBA
03/2015
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
03/2015
1Indicators and Reagents (Reagents)IBA
07/2010
1Messenger RNA (mRNA)IBA
04/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2007
1Rituximab (Mabthera)FDA Link
10/2006
1OligonucleotidesIBA
10/2006
1SolutionsIBA
03/2006
1Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2006
1PotassiumIBA
03/2006
1DNA (Deoxyribonucleic Acid)IBA
06/2004

Therapy/Procedure

7Therapeutics
10/2022 - 07/2007
3Drug Therapy (Chemotherapy)
01/2019 - 10/2006
1Castration
10/2015
1Time-to-Treatment
10/2006